retatrutide phase 2 diabetes weight loss 2024 2: Type and Key Trial Findings – Bolt Pharmacy VisualAbstract: Retatrutide reduces body weight

A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks

If it's not, it may not be undergoing inspections or complying with other laws

The Precision Peptide Genetic Test identifies variations in GLP1R and GIPR genes that influence how your body responds to dose changes, helping optimize your discontinuation timeline

Some individuals may lose a smaller percentage, while others achieve more dramatic results depending on factors like diet, exercise, metabolism, and adherence to the program